Should molnupiravir be used for covid-19 outpatient management in individuals at high risk for disease severity? A systematic review and meta-analysis of randomized controlled trials. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 60, 2024. DOI: 10.1590/. Disponível em: https://journals.usp.br/bjps/article/view/231188.. Acesso em: 3 dec. 2024.